Scientists dive deep into endocrine tumors to unlock molecular secrets

NCT ID NCT01005654

First seen Jun 24, 2026 · Last updated Aug 05, 2026 · Updated 8 times

Summary

This study enrolls people with endocrine tumors (such as thyroid, parathyroid, adrenal, or pancreatic tumors) who are scheduled for surgery or biopsy. Researchers collect samples of the tumor, nearby healthy tissue, blood, and urine to analyze genetic and molecular changes. The goal is to better understand how these tumors develop and to find ways to distinguish benign from malignant growths, which could improve future diagnosis and treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could help doctors better tell apart benign from malignant endocrine tumors, leading to more accurate diagnoses and personalized treatments.
What could go wrong
This is an observational study, not a treatment trial. It collects data and samples but does not test a new therapy, so direct patient benefits may take years to emerge.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADRENAL NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.